Stem cell differentiation and lumen formation in colorectal cancer cell lines and primary tumors

Cancer Research

Volumn 73, Issue 18, 2013, Pages 5798-5809

  Ashley, Neil ^a   Yeung, Trevor M ^a   Bodmer, Walter F ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

F ACTIN; INTESTINE ENZYME; PROTEIN HIF1; TRANSCRIPTION FACTOR CDX1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CDX1 GENE; CELL DIFFERENTIATION; CELL HYPOXIA; COLORECTAL CANCER; FEMALE; GENE SILENCING; HOMEOBOX; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CELL; INTESTINE EPITHELIUM; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TIGHT JUNCTION; TUMOR DIFFERENTIATION;

ANIMALS; ANOXIA; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; COLON; COLORECTAL NEOPLASMS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS;

EID: 84884774935     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-0454     Document Type: Article

References (37)

1. Potten CS, Booth C, Pritchard DM. The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol 1997;78:219-43.
2. Lacroix B, Kedinger M, Simon-Assmann P, Rousset M, Zweibaum A, Haffen K. Developmental pattern of brush border enzymes in the human fetal colon. Correlation with some morphogenetic events. Early Hum Dev 1984;9:95-103.
3. Holmes R. The intestinal brush border. Gut 1971;12:668-77.
4. Holmes R, Lobley RW. Intestinal brush border revisited. Gut 1989; 30:1667-78.
5. Carboni JM, Howe CL, West AB, Barwick KW, Mooseker MS, Morrow JS. Characterization of intestinal brush border cytoskeletal proteins of normal and neoplastic human epithelial cells. A comparison with the avian brush border. Am J Pathol 1987;129:589- 600.
6. West AB, Isaac CA, Carboni JM, Morrow JS, Mooseker MS, Barwick KW. Localization of villin, a cytoskeletal protein specific tomicrovilli, in human ileum and colon and in colonic neoplasms. Gastroenterology 1988;94:343-52.
7. Zweibaum A, Hauri HP, Sterchi E, Chantret I, Haffen K, Bamat J, et al. Immunohistological evidence, obtained with monoclonal antibodies, of small intestinal brush border hydrolases inhuman colon cancers and foetal colons. Int J Cancer 1984;34:591-8.
8. Hamilton SR, Aaltonen LA. World Health Organization classification of tumors: pathology and genetics of tumors of the digestive system. IARC Press; Lyon, France; 2000.
9. Hinoi T, Tani M, Lucas PC, Caca K, Dunn RL, Macri E, et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol 2001;159:2239-48.
10. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-5.
11. Ashley N. Regulation of intestinal cancer stem cells. Cancer Lett. 2012 Apr 27. [Epub ahead of print].
12. Richman P, Bodmer W. Control of differentiation in human colorectal carcinoma cell lines: epithelial-mesenchymal interactions. Pathol J 1988;156:197-211.
13. Del Buono R, Pignatelli M, Bodmer WF, Wright NA. The role of the arginine-glycine-aspartic acid-directed cellular binding to type I collagen and rat mesenchymal cells in colorectal tumour differentiation. Differentiation 1991;46:97-103.
14. Yeung TM, Gandhi SC, Wilding JL, Muschel R, Bodmer WF. Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci U S A 2010;107:3722-7.
15. Yeung TM, Gandhi SC, Bodmer WF. Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci US A 2011;108:4382-7.
16. Chan CW, Wong NA, Liu Y, Bicknell D, Turley H, Hollins L, et al. Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1. Proc Natl Acad Sci U S A 2009;106: 1936-41.
17. Wong NA, Britton MP, Choi GS, Stanton TK, Bicknell DC, Wilding JL, et al. Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. Proc Natl Acad Sci U S A 2004;101:574-9.
18. Arango D, Al-Obaidi S, Williams DS, Dopeso H, Mazzolini R, Corner G, et al. Villin expression is frequently lost in poorly differentiated colon cancer. Am J Pathol 2012;180:1509-21.
19. Staloch LJ, Divine JK, Witten JT, Simon TC. C/EBP and Cdx family factors regulate liver fatty acid binding protein transgene expression in the small intestinal epithelium. Biochim Biophys Acta 2005;1731: 168-78.
20. Ashley N, Poulton J. Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling. Oncogene 2009;28: 3880-91.
21. Pittman FE, Pittman JC. An electron microscopic study of epithelium of normal human sigmoid colonic mucosa. Gut 1966;7:644-61.
22. Bretscher A, Weber K. Localization of actin and microfilament-associated proteins in the microvilli and terminal web of the intestinal brush border by immunofluorescence microscopy. J Cell Biol 1978;79: 839-45.
23. Polak-Charcon S, Shoham J, Ben-Shaul Y. Tight junctions in epithelial cells ofhuman fetal hindgut, normal colon, and colon adenocarcinoma. J Natl Cancer Inst 1980;65:53-62.
24. Chan DA, Sutphin PD, Denko NC, Giaccia AJ. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 2002;277:40112-7.
25. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 2008;105:13427-32.
26. Emmink BL, Van Houdt WJ, Vries RG, Hoogwater FJ, Govaert KM, Verheem A, et al. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology 2011;141: 269-78.
27. Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci- Vitiani L, et al. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 2011;140:297-309.
28. Odoux C, Fohrer H, Hoppo T, Guzik L, Stolz DB, Lewis DW, et al. A stochastic model for cancer stemcell origin in metastatic colon cancer. Cancer Res 2008;68:6932-41.
29. Keller MS, Ezaki T, Guo RJ, Lynch JP. Cdx1 or Cdx2 expression activates E-cadherin-mediated cell-cell adhesion and compaction in human COLO 205 cells. Am J Physiol Gastrointest Liver Physiol 2004;287:G104-114.
30. Gao N, Kaestner KH. Cdx2 regulates endo-lysosomal function and epithelial cell polarity. Genes Dev 2010;24:1295-305.
31. Merlos-Suarez A, Barriga FM, Jung P, Iglesias M, Cespedes MV, Rossell D, et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011;8: 511-24.
32. de Sousa E, Melo F, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH, et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 2011;9:476-85.
33. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-7.
34. Jung P, Sato T, Merlos-Suarez A, Barriga FM, Iglesias M, Rossell D, et al. Isolation and in vitro expansion of human colonic stem cells. Nat Med 2011;17:1225-7.
35. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, Washington MK, et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 2012;149:146-58.
36. Kemper K, Prasetyanti PR, De Lau W, Rodermond H, Clevers H, Medema JP. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells 2012;30:2378-86.
37. Kobayashi S, Yamada-Okabe H, Suzuki M, Natori O, Kato A, Matsubara K, et al. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution. Stem Cells 2012;30:2631-44.